Since August 1, 2026, Doctolib has been using its patients' health data for a large-scale artificial intelligence research project, unless they explicitly object. The platform, used by more than 50 million people in France, has launched a program called “Improving Care Pathways Through Artificial Intelligence,” carried out over three years with Inria (France's national institute for research in digital science and technology), Inserm (France's National Institute of Health and Medical Research), and Université Paris Cité.
A Three-Year Research Program
Contents
The project, led by the HeKA team (Inria, Inserm, Paris Cité), aims to develop tools capable of better identifying certain health risks, making it easier to monitor patients, and improving care coordination among healthcare professionals. To do this, Doctolib plans to use the demographic and health data entered by patients or their doctors on the platform.
Doctolib states that this information will be pseudonymized — meaning separated from patients' identities — kept for a maximum of five years before being deleted, and that it will neither be resold for commercial purposes nor used to train the company's own AI models.
A Legal Framework Based on Opt-Out
The initiative relies on MR-004, a reference methodology from the CNIL (France's data protection authority), which allows health data to be reused for public-interest research without prior consent, provided that the people concerned are informed and can object. This mechanism, legal but controversial, has drawn criticism from consumer and rights advocacy groups: unlike an opt-in system, it places the burden on anyone who wants to refuse to share their data to take active steps.
To object to this data collection, patients can click the link included in the email sent by Doctolib, fill out a dedicated form citing Article 56 of the French Data Protection Act (loi Informatique et Libertés), or write directly to [email protected]. Objections remain possible before the project officially begins or to request the withdrawal of one's data during the research, but no longer once the work has been completed, so as not to compromise its scientific validity.
What This Means for Patients
- Anyone registered with Doctolib who has provided medical information is potentially affected, without any prior action on their part.
- Silence means consent: without an explicit objection, the data may be included in the research project.
- The data remains pseudonymized and limited to a controlled research use, separate from Doctolib's commercial tools.
- This case illustrates a broader debate about the balance between innovation in artificial intelligence applied to health care and privacy protection.
This kind of arrangement is part of a broader trend: as AI tools become more widespread, more and more digital and health care companies are relying on large databases to train or power their models, often through opt-out mechanisms that are not very visible to the general public. A few simple tips can help you stay in control of your personal information: regularly check your notification emails, read the terms of use of health care platforms, and contact the data protection department directly if in doubt.
Frequently Asked Questions
Who is affected by Doctolib's AI research project?
Anyone with a Doctolib account who has entered demographic or medical information, whether on their own or through a healthcare professional, potentially falls within the scope of the program launched in August 2026.
How can I refuse to have my data used?
Simply click the opt-out link included in the email sent by Doctolib, fill out the dedicated form citing Article 56 of the French Data Protection Act, or write to [email protected] before the project begins.
Will my data be used to train commercial AI models?
No. According to Doctolib, the pseudonymized data from this program is reserved for research conducted with Inria, Inserm, and Université Paris Cité, and is not used to train the company's own AI models or for commercial purposes.
Sources
- Que Choisir — How to Stop Doctolib From Using Your Data for Its AI Research Project
- Génération NT — Doctolib Wants to Use Your Health Data for AI
- CNEWS — How to Object to Doctolib's Collection of Your Health Data
Author Profile
Latest entries
Planet15 November 2026CO2 Emissions: Why Transportation Remains France's Climate Blind Spot
Artificial Intelligence12 November 2026Imagine Enterprise: IBM and Microsoft Team Up on AI Agents for Large Businesses
Economy11 November 2026Livret A Rate: Understanding How It's Calculated and Its Limits
Shopping8 November 2026Black Friday: Key Dates and the Budget French Shoppers Are Planning
This article was written with the help of artificial intelligence. Editorial policy









